从指南到实践:药师主导的前瞻性审核与反馈改进模型在南非34家医院的围手术期抗生素预防应用
该研究在南非34家城乡医院实施药师主导的前瞻性审核与反馈策略,以改善围手术期抗生素预防(PAP)对指南的依从性并降低手术部位感染(SSI)。结论认为药师主导的流程改进可有效提高PAP指南依从性并改善患者结局。
要点
- 药师主导的前瞻性审核与反馈可显著提高PAP复合依从率(66.8%→83.3%)。
- 该干预与SSI率下降相关(2.46%→1.97%,P=0.0029)。
- 模型利用现有资源,适用于城乡异质性医院。
核心结论
- 药师主导的流程改进举措能有效提高PAP指南依从性并可持续改善患者结局。
研究设计与样本
- 前瞻性审核与反馈策略,包含变革管理与改进原则,为期2.5年,在南非34家城乡医院实施。
- 干预包括预实施阶段在试点机构测试PAP指南与工具包,随后在所有机构推广,并进行基线SSI和四项过程指标依从性调查。
主要发现
- 复合依从率从66.8%(95%CI 64.8-68.7)提高至83.3%(95%CI 80.8-85.8),相对增加24.7%(P<0.0001)。
- SSI率从干预前均值2.46(95%CI 2.18-2.73)降至干预后1.97(95%CI 1.79-2.15),下降19.7%(P=0.0029)。
关键数值与推荐
- 四项过程指标包括抗生素选择、剂量、给药时间和疗程。
- 复合依从率从66.8%(95%CI 64.8-68.7)提升至83.3%(95%CI 80.8-85.8)。
- SSI率从2.46(95%CI 2.18-2.73)降至1.97(95%CI 1.79-2.15)。
临床怎么用
- 可借鉴该药师主导的前瞻性审核与反馈模型,结合机构需求制定改进措施以提高PAP指南依从性。
- 定期审核与反馈过程指标(选择、剂量、时机、疗程)有助于持续改进。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Few data exist on the implementation of process measures to facilitate adherence to peri-operative antibiotic prophylaxis (PAP) guidelines in Africa. OBJECTIVES: To implement an improvement model for PAP utilizing existing resources, in order to achieve a reduction in surgical site infections (SSIs) across a heterogeneous group of 34 urban and rural South African hospitals. METHODS: A pharmacist-driven, prospective audit and feedback strategy involving change management and improvement principles was utilized. This 2.5 year intervention involved a pre-implementation phase to test a PAP guideline and a 'toolkit' at pilot sites. Following antimicrobial stewardship committee and clinician endorsement, the model was introduced in all institutions and a survey of baseline SSI and compliance rates with four process measures (antibiotic choice, dose, administration time and duration) was performed. The post-implementation phase involved audit, intervention and monthly feedback to facilitate improvements in compliance. RESULTS: For 70 weeks of standardized measurements and feedback, 24 206 surgical cases were reviewed. There was a significant improvement in compliance with all process measures (composite compliance) from 66.8% (95% CI 64.8-68.7) to 83.3% (95% CI 80.8-85.8), representing a 24.7% increase ( P < 0.0001). The SSI rate decreased by 19.7% from a mean group rate of 2.46 (95% CI 2.18-2.73) pre-intervention to 1.97 post-intervention (95% CI 1.79-2.15) ( P = 0.0029). CONCLUSIONS: The implementation of process improvement initiatives and principles targeted to institutional needs utilizing pharmacists can effectively improve PAP guideline compliance and sustainable patient outcomes.
引用
- Brink AJ, Messina AP, Feldman C, et al. From guidelines to practice: a pharmacist-driven prospective audit and feedback improvement model for peri-operative antibiotic prophylaxis in 34 South African hospitals. J Antimicrob Chemother. 2017. PMID: 27999061. doi:10.1093/jac/dkw523
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。